IFPMA Code of Practice e-learning

Over time, as the world and culture changes, medicine faces new challenges, such as urgently finding a solution for COVID-19. The pharmaceutical industry, as the main sector responsible for creating medicines and vaccines, has to meet the highest standard of ethics and transparency throughout its production chain. This industry requires that all its suppliers, employees…

CECMED-FIFARMA Project presented in the 2020 DIA Global Conference

As the PANDRH CPP Project reaches a milestone, FIFARMA recognizes CECMED’s Director Dr Pérez Cristiá for his role in this successful initiative. The Project The PANDRH Network is an initiative of National Regulatory Authorities (NRAs) in the Region of the Americas and regional industry associations, including FIFARMA. The technical work of the PANDRH Network supports…

Economic challenges during and after COVID-19

COVID-19 has introduced great economic challenges for the countries around the world. The beginning of the pandemic was characterized by deep uncertainty and governments that decided to lockdown cities to reduce the risk of infection. Countries now have more epidemiological and economic available data and, therefore, are trying to manage progressive economic reactivation. Economic shock…

Coronavirus vaccine is changing science

It is no secret to anyone that science does not have all answers desired by the world and that there is currently a race-against-the-virus scenario. However, this could be favorable for research and medical development. One of the stories to be told in the coming years will be the accelerated scientific development that responded to…

Telemedicine in Latin America during COVID-19

On February 26th, 2020, Latin Americans ceased to be coronavirus spectators and began enduring its effects in their own flesh. Since then, a fragile and unprepared healthcare system for a pandemic has been exposed. As a result, initiatives such as telemedicine have gained strength and have been positioned as an alternative to traditional medicine. Telemedicine…

COVID19 clinical research challenges and opportunities

On May 20th, the International Clinical Trials Day was celebrated.  It was on January 1922 when Leonard Thompson, a 14-year-old diabetic who was about to die at Toronto General Hospital, was the first receiving insulin, discovered by scientists Frederick Grant Banting and Charles Herber Best. Day by day, after administering the medicine, the miraculous recovery…

Importance of Ethics during COVID-19

Some experts explain that the real big problem of this crisis is that there are more patients than can be taken care of, and this creates shortages in the healthcare staff and medicines, so the question during this pandemic is: how are more lives saved? That was pointed out by Kenneth Prager, Director of Clinical…

Innovation in Times of COVID-19

On March 25, 2020, a consortium of life science companies with  the Bill & Melinda Gates Foundation announced a collaboration to promote the development, manufacture, and delivery of diagnostics and treatments to combat COVID-19.  With extensive years of expertise in the healthcare sector and the pharmaceutical research, these expert companies will raise financial aid and…